April 18, 2018

AACR-Mark Foundation NextGen Grant for Transformative Cancer Research

L to R: Michele Cleary, PhD, CEO, The Mark Foundation; Birgit Knoechel, MD, PhD, Dana-Farber Cancer Institute; Michael A. Caligiuri, MD, Immediate Past President, AACR

In partnership with the American Association for Cancer Research, The Mark Foundation is pleased to announce that Dr. Birgit Knoechel is the recipient of the inaugural AACR-Mark Foundation NextGen Grant for Transformative Cancer Research. This award will support Dr. Knoechel’s efforts to develop new therapies for leukemia.

Dr. Knoechel is a clinician-scientist who performs research and treats patients with pediatric leukemia. Individual leukemia cells in a single patient can vary significantly in their characteristics and behaviors. Dr. Knoechel’s lab studies how variation in a population of cancer cells can contribute to resistance to a targeted leukemia therapy. By understanding how and why these therapies fail to work, strategies can be developed to overcome resistance and successfully treat children with this type of leukemia. Follow this link for AACR’s full press release.